The diabetes drug delivery devices market is estimated to be worth USD 31 billion in 2030, predicts Roots Analysis

Owing to over a decade of extensive R&D, the novel diabetes drug delivery devices, such as insulin pumps and pen-injectors, offer a safe and convenient solution to diabetic patients who are required to medicate on a frequent basis

• More than 80 devices are available / under development for the delivery of various pharmacological interventions, via a variety of routes, for the treatment of diabetes
• The market landscape is fragmented, featuring both new entrants (small companies) and established players (mid-large sized enterprises); the US is currently considered to be a hub of innovation related to insulin delivery devices
• Leveraging their expertise, stakeholders within this domain are developing a myriad of invasive and non-invasive diabetes drug delivery devices that can administer drugs through different routes
• In order to achieve an edge over competing players, drug delivery device developers are actively focusing on the integration / inclusion of novel / advanced features in their respective products / offerings

Roots Analysis is pleased to announce the publication of its recent study, titled, “Diabetes Drug Delivery Devices Market, 2020-2030”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these devices over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

• A detailed assessment of the current market landscape of device developers engaged in the development of diabetes drug delivery devices.
• A detailed competitive analysis of diabetes drug delivery devices based on supplier power and product specifications.
• An analysis of the partnerships that have been inked by the stakeholders in this domain, in the recent past.
• Detailed profiles of developers of diabetes drug delivery devices (shortlisted on the basis of the number of devices developed).
• An analysis of recent initiatives undertaken by big pharma players engaged in this domain.
• A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

• Type of Device
• Pen-Injectors
• Insulin Pumps
• Conventional Syringes
• Others
• Route of Administration
• Subcutaneous
• Intravenous
• Others
• Type of Diabetes
• Type 1
• Type 2
• Usability of the Device
• Disposable
• Reusable
• Key Geographies
• North America
• Europe
• Asia Pacific
• Rest of the World

Key companies covered in the report 

• Bigfoot Biomedical
• Debiotech
• Haselmeier
• Medtronic
• Novo Nordisk
• Roche
• SOOIL
• Ypsomed

For more information please click on the following link:

https://www.rootsanalysis.com/reports/diabetes-drug-delivery-devices-market.html or email [email protected]

Other Recent Offerings

1. Organ–based / Targeted Drug Delivery Devices Market for Biologics (Intra-organ / Intra-tumoral), 2020 - 2030
2. Global Handheld Ultrasound Imaging Devices Market, 2020-2030
3. Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices
4. Medical Device CROs Market (2nd Edition), 2020 – 2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]